IART vs RTX · rev $810.7M vs P/E 36, rev $46.78B
Integra LifeSciences Holdings (IART) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported IART revenue for 2026-06-30 was $810.7M. Net income was -$134.0K. IART currently screens at market cap $1.32B.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
IART currently screens at market cap $1.32B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the IART and RTX stock pages for the full models.
Not investment advice.